Spots Global Cancer Trial Database for yondelis
Every month we try and update this database with for yondelis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT01846611 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | Trabectedin DOXIL Dexamethasone DOXIL | 18 Years - | Janssen Research & Development, LLC | |
| A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma | NCT01343277 | Advanced Liposa... | Trabectedin Dacarbazine | 15 Years - | Janssen Research & Development, LLC | |
| An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) | NCT00796120 | Sarcoma | Trabectedin Doxorubicin Ifosfamide | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer | NCT00060944 | Liposarcoma Leiomyosarcoma | Yondelis Yondelis Dexamethasone Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma | NCT01692678 | Advanced or Met... | Trabectedin Dacarbazine | 15 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer | NCT00580112 | Breast Neoplasm... | Dexamethasone Trabectedin | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma | NCT00102609 | Soft Tissue Sar... Sarcoma Neoplasms, Conn... Neoplasms by Hi... Neoplasms | Doxorubicin Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer | NCT00060944 | Liposarcoma Leiomyosarcoma | Yondelis Yondelis Dexamethasone Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer | NCT00050427 | Breast Neoplasm... Neoplasms Neoplasms by Si... Breast Diseases Skin Diseases | ET743 ET743 | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer | NCT00072670 | Prostate Cancer | Trabectedin | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | NCT00786838 | Solid Tumor | Trabectedin Placebo | 18 Years - 65 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | NCT00786838 | Solid Tumor | Trabectedin Placebo | 18 Years - 65 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| ET 743 (Yondelis) in Men With Advanced Prostate Cancer | NCT00147212 | Prostate Cancer | ET 743 | 18 Years - | Massachusetts General Hospital | |
| An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer | NCT00113607 | Ovarian Cancer | Trabectedin DOXIL Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT01846611 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | Trabectedin DOXIL Dexamethasone DOXIL | 18 Years - | Janssen Research & Development, LLC | |
| A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer | NCT00072670 | Prostate Cancer | Trabectedin | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
